Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-22-002440
Filing Date
2022-03-03
Accepted
2022-03-03 20:07:19
Documents
1
Period of Report
2022-03-01

Document Format Files

Seq Description Document Type Size
1 form4-03032022_050357.html 4  
1 form4-03032022_050357.xml 4 5706
  Complete submission text file 0001415889-22-002440.txt   7041
Mailing Address 45 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 45 SIDNEY STREET CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Issuer) CIK: 0001597264 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address BLUEPRINT MEDICINES CORPORATION 38 SIDNEY STREET, SUITE 200 CAMBRIDGE MA 02139
Business Address
Haviland Kate (Reporting) CIK: 0001663022 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37359 | Film No.: 22711572